ALK-Abello A/S Present Successful Phase III Clinical Study Results with Children
3/17/2008 6:31:38 AM
More...
|
Catalent Pharma Solutions Signs Agreement with ALK-Abello A/S to Expand Zydis Production Capacity
8/29/2007 7:32:03 AM
More...
|
Schering-Plough Corporation (SGP) To Sell Danish ALK-Abello A/S Anti-Allergy Drug; ALK-Abello Will Receive Upfront $35M
1/3/2007 12:20:06 PM
More...
|
New Study Reinforces Safety And Clinical Efficacy Of ALK-Abello A/S's Tablet Against Grass Pollen Allergy
10/19/2005 5:11:56 PM
More...
|
Schering-Plough Corporation (SGP) Abandons Drug; Ending The Collaboration With ALK-Abello A/S
10/19/2005 5:09:31 PM
More...
|